Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043

This study has been withdrawn prior to enrollment.

(The compound is being re-evaluated)

Sponsor:

Information provided by:

AstraZeneca

ClinicalTrials.gov Identifier:

NCT01086813

First received: March 9, 2010

Last updated: December 19, 2012

Last verified: December 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	April 2010
Estimated Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)